2-styryl-2-imidazoline

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2013

2013

Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain.

Celia Garau, Antonio Miralles, Jesús Andrés García-Sevilla
Journal of psychopharmacology
2013

Selective I(2)-imidazoline receptor ligands induce neuroprotection through various molecular mechanisms including blockade of N… (More)

Is this relevant?

Highly Cited

1999

Highly Cited

1999

Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.

Gabriel Olmos, Núria DeGregorio-Rocasolano, +6 authors Jesús Andrés García-Sevilla
British journal of pharmacology
1999

This study was designed to assess the potential neuroprotective effect of several imidazol(ine) drugs and agmatine on glutamate… (More)

Is this relevant?

1999

1999

Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo

Antoni Sastre-Coll, Susana Esteban, Jesús Andrés García-Sevilla
Naunyn-Schmiedeberg's Archives of Pharmacology
1999

This study was designed to assess the effects of imidazoline drugs on putative presynaptic imidazoline receptors modulating brain… (More)

Is this relevant?

1997

1997

Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.

Andrés Ozaita, Genaro Olmos, M. Assumpció Boronat, José Miguel Lizcano, Mercedes Unzeta, Jesús Andrés García-Sevilla
British journal of pharmacology
1997

1. I2-Imidazoline sites ([3H]-idazoxan binding) have been identified on monoamine oxidase (MAO) and proposed to modulate the… (More)

Is this relevant?